Brazil Pharmaceuticals and Healthcare Report - Q4 2014

Business Monitor International
September 10, 2014
168 Pages - SKU: BMI5325534
Countries covered: Brazil

Brazil Pharmaceuticals and Healthcare Report - Q4 2014

BMI View: Brazil's traditional commitment to healthcare, strong government support for the provision ofmedical services, promising private healthcare growth and the expanding middle-class mean that there aresignificant revenue-generating opportunities for drugmakers, medical device companies and healthcareservice providers. However, multinationals will continue to face increasing government intervention anddomestic competition.

Headline Expenditure Projections

Pharmaceuticals: BRL57.0bn (USD26.4bn) in 2013 to BRL62.0bn (USD26.6bn) in 2014; +8.8% inlocal currency terms and +0.8% in US dollar terms. Forecast revised upwards from Q314 due tochanges to macroeconomic forecast.



More Prescription Drugs reports by Business Monitor International

Japan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Japan Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Japanese pharmaceutical market continues to hold strong rewards for innovativepharmaceutical companies. This is driven by the ...
Tanzania Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Tanzania Pharmaceuticals and Healthcare Report Q1 2015BMI View: We expect the continuing depreciation of the Tanzanian shilling to make imports of rawmaterials increasingly expensive for ...
Romania Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Romania Pharmaceuticals and Healthcare Report Q1 2015BMI View: Romania's claw back tax is likely to see a revision as domestic companies lobby to push theburden ...
Latvia Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Latvia Pharmaceuticals and Healthcare Report Q1 2015BMI View: Market growth forecasts are strong although the country will continue to present a modestopportunity to larger multinational ...
See all reports like this >>

More Brazil Prescription Drugs reports

Databook Q1 2014: Brazil Digital Advertising Spend - Pharmaceutical & Healthcare Industry by Socintel360
Databook Q1 2014: Brazil Digital Advertising Spend in Pharmaceutical & Healthcare IndustryOnline advertising spend by pharmaceutical & healthcare brands in Brazil stood at US$84 million ...
Databook Q1 2014: Brazil Social Media Advertising Spend - Pharmaceutical & Healthcare Industry by Socintel360
Databook Q1 2014: Brazil Social Media Advertising Spend in Pharmaceutical & Healthcare IndustrySocial media advertising spend by pharmaceutical & healthcare brands in Brazil stood at ...
Pharmaceuticals and Healthcare : Brazil Pharmaceuticals and Healthcare Report Q3 2014 by Business Monitor International
Pharmaceuticals and Healthcare : Brazil Pharmaceuticals and Healthcare Report Q3 2014BMI View: The Brazilian pharmaceutical market will continue to be the most attractive to multinationalpharmaceutical ...
Pharmaceuticals: BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Pharmaceuticals: BRIC (Brazil, Russia, India, China) Industry GuideIntroductionThe BRIC Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and ...
See all reports like this >>

More Brazil reports

Spirits - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
IntroductionThe BRIC Spirits industry guide provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2009-13, and forecast to 2018). ...
Chemicals: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide by MarketLine
Chemicals: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide is an essential resource for top-level data and analysis covering the Chemicals ...
Soft Drinks: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide by MarketLine
Datamonitor's Soft Drinks: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide is an essential resource for top-level data and analysis covering ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!